Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Prescriptions for Alpha Agonists and Antipsychotics in Children and Youth with Tic Disorders: A Pharmacoepidemiologic Study.

Cothros N, Martino D, McMorris C, Stewart D, Tehrani A, Pringsheim T.

Tremor Other Hyperkinet Mov (N Y). 2019 Jul 15;9. doi: 10.7916/tohm.v0.645. eCollection 2019.

2.

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Hershey AD, Licking N, Sowell M, Victorio MC, Gersz EM, Leininger E, Zanitsch H, Yonker M, Mack K.

Neurology. 2019 Aug 14. pii: 10.1212/WNL.0000000000008095. doi: 10.1212/WNL.0000000000008095. [Epub ahead of print]

PMID:
31413171
3.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, Holler-Managan Y, Leininger E, Licking N, Mack K, Powers SW, Sowell M, Victorio MC, Yonker M, Zanitsch H, Hershey AD.

Neurology. 2019 Aug 14. pii: 10.1212/WNL.0000000000008105. doi: 10.1212/WNL.0000000000008105. [Epub ahead of print]

PMID:
31413170
4.

The Pharmacoepidemiology of Psychotropic Medication Use in Canadian Children from 2012 to 2016.

Pringsheim T, Stewart DG, Chan P, Tehrani A, Patten SB.

J Child Adolesc Psychopharmacol. 2019 Jul 29. doi: 10.1089/cap.2019.0018. [Epub ahead of print]

PMID:
31355670
5.

Effect of diet, exercise and sleep on tic severity: a scoping review protocol.

Nosratmirshekarlou E, Shafiq S, Goodarzi ZS, Martino D, Pringsheim T.

BMJ Open. 2019 Jul 9;9(7):e024653. doi: 10.1136/bmjopen-2018-024653.

6.

Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.

Pringsheim T, Holler-Managan Y, Okun MS, Jankovic J, Piacentini J, Cavanna AE, Martino D, Müller-Vahl K, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M.

Neurology. 2019 May 7;92(19):907-915. doi: 10.1212/WNL.0000000000007467.

PMID:
31061209
7.

Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.

Pringsheim T, Okun MS, Müller-Vahl K, Martino D, Jankovic J, Cavanna AE, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M, Holler-Managan Y, Piacentini J.

Neurology. 2019 May 7;92(19):896-906. doi: 10.1212/WNL.0000000000007466.

PMID:
31061208
8.

Detection of anxiety symptoms in persons with dementia: A systematic review.

Goodarzi Z, Samii L, Azeem F, Sekhon R, Crites S, Pringsheim T, Smith EE, Ismail Z, Holroyd-Leduc J.

Alzheimers Dement (Amst). 2019 Apr 22;11:340-347. doi: 10.1016/j.dadm.2019.02.005. eCollection 2019 Dec.

9.

Exploring the Decisional needs of Parents with Children with ADHD and Disruptive and Aggressive Behaviour.

Nosratmirshekarlou E, Andrade BF, Jette N, Lawson ML, Pringsheim T.

J Can Acad Child Adolesc Psychiatry. 2019 Apr;28(1):30-41. Epub 2019 Mar 1.

10.

Treatment Recommendations for Tardive Dyskinesia.

Ricciardi L, Pringsheim T, Barnes TRE, Martino D, Gardner D, Remington G, Addington D, Morgante F, Poole N, Carson A, Edwards M.

Can J Psychiatry. 2019 Jun;64(6):388-399. doi: 10.1177/0706743719828968. Epub 2019 Feb 21.

PMID:
30791698
11.

Correction: Age-specific global epidemiology of hydrocephalus: Systematic review, metanalysis and global birth surveillance.

Isaacs AM, Riva-Cambrin J, Yavin D, Hockley A, Pringsheim TM, Jette N, Lethebe BC, Lowerison M, Dronyk J, Hamilton MG.

PLoS One. 2019 Jan 10;14(1):e0210851. doi: 10.1371/journal.pone.0210851. eCollection 2019.

12.

Tic-related obsessive–compulsive disorder

Pringsheim T, Piacentini J.

J Psychiatry Neurosci. 2018 Nov 1;43(6):431-432. No abstract available.

13.

Underrepresentation of women in Parkinson's disease trials.

Tosserams A, Araújo R, Pringsheim T, Post B, Darweesh SKL, IntHout J, Bloem BR.

Mov Disord. 2018 Nov;33(11):1825-1826. doi: 10.1002/mds.27505. Epub 2018 Oct 11. No abstract available.

PMID:
30311268
14.

Age-specific global epidemiology of hydrocephalus: Systematic review, metanalysis and global birth surveillance.

Isaacs AM, Riva-Cambrin J, Yavin D, Hockley A, Pringsheim TM, Jette N, Lethebe BC, Lowerison M, Dronyk J, Hamilton MG.

PLoS One. 2018 Oct 1;13(10):e0204926. doi: 10.1371/journal.pone.0204926. eCollection 2018. Erratum in: PLoS One. 2019 Jan 10;14(1):e0210851.

15.

Author response: Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Aug 21;91(8):373-374. doi: 10.1212/WNL.0000000000006042. No abstract available.

PMID:
30126885
16.

Identifying priority outcomes that influence selection of disease-modifying therapies in MS.

Day GS, Rae-Grant A, Armstrong MJ, Pringsheim T, Cofield SS, Marrie RA.

Neurol Clin Pract. 2018 Jun;8(3):179-185. doi: 10.1212/CPJ.0000000000000449.

17.

Using antipsychotics for behavioral problems in children.

Shafiq S, Pringsheim T.

Expert Opin Pharmacother. 2018 Sep;19(13):1475-1488. doi: 10.1080/14656566.2018.1509069. Epub 2018 Aug 13. Review.

PMID:
30102079
18.

The prevalence of diagnosed obsessive compulsive disorder and associated comorbidities: A population-based Canadian study.

Osland S, Arnold PD, Pringsheim T.

Psychiatry Res. 2018 Oct;268:137-142. doi: 10.1016/j.psychres.2018.07.018. Epub 2018 Jul 11.

PMID:
30025284
19.

Second-generation antipsychotics and metabolic side-effects: Canadian population-based study.

Hirsch L, Patten SB, Bresee L, Jette N, Pringsheim T.

BJPsych Open. 2018 Jul;4(4):256-261. doi: 10.1192/bjo.2018.33.

20.

Antipsychotic Drug-Induced Movement Disorders: A Forgotten Problem?

Pringsheim T, Barnes TRE.

Can J Psychiatry. 2018 Jan 1:706743718786702. doi: 10.1177/0706743718786702. [Epub ahead of print] No abstract available.

21.

Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.

Osland ST, Steeves TD, Pringsheim T.

Cochrane Database Syst Rev. 2018 Jun 26;6:CD007990. doi: 10.1002/14651858.CD007990.pub3. Review.

22.

Miming neurological syndromes improves medical student's long-term retention and delayed recall of neurology.

Roze E, Worbe Y, Louapre C, Méneret A, Delorme C, McGovern E, Ruiz M, Capron J, Le Bouc R, Epelbaum S, Alamowitch S, Duguet A, Renaud MC, Palombi O, Pringsheim TM, Flamand-Roze C, Steichen O.

J Neurol Sci. 2018 Aug 15;391:143-148. doi: 10.1016/j.jns.2018.06.003. Epub 2018 Jun 7.

PMID:
29910128
23.

Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis.

Martino D, Karnik V, Osland S, Barnes TRE, Pringsheim TM.

Can J Psychiatry. 2018 Jan 1:706743718777392. doi: 10.1177/0706743718777392. [Epub ahead of print]

24.

The lesser of two evils: a qualitative study of quetiapine prescribing by family physicians.

Kelly M, Dornan T, Pringsheim T.

CMAJ Open. 2018 Apr 30;6(2):E191-E196. doi: 10.9778/cmajo.20170145.

25.

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):789-800. doi: 10.1212/WNL.0000000000005345. Review.

PMID:
29686117
26.

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):777-788. doi: 10.1212/WNL.0000000000005347. Erratum in: Neurology. 2019 Jan 8;92(2):112.

PMID:
29686116
27.

The Assessment and Treatment of Antipsychotic-Induced Akathisia.

Pringsheim T, Gardner D, Addington D, Martino D, Morgante F, Ricciardi L, Poole N, Remington G, Edwards M, Carson A, Barnes TRE.

Can J Psychiatry. 2018 Jan 1:706743718760288. doi: 10.1177/0706743718760288. [Epub ahead of print]

28.

Antipsychotic Drug-Induced Movement Disorders: A Forgotten Problem?

Pringsheim T, Barnes TRE.

Can J Psychiatry. 2018 Jan 1:706743718772526. doi: 10.1177/0706743718772526. [Epub ahead of print] No abstract available.

PMID:
29685067
29.

Effects of depression and anxiety on quality of life in five common neurological disorders.

Prisnie JC, Sajobi TT, Wang M, Patten SB, Fiest KM, Bulloch AGM, Pringsheim T, Wiebe S, Jette N.

Gen Hosp Psychiatry. 2018 May - Jun;52:58-63. doi: 10.1016/j.genhosppsych.2018.03.009. Epub 2018 Apr 4.

PMID:
29684713
30.

Alternating hemiplegia of childhood: Clinical case and video description.

Au K, Pringsheim T.

Neurol Clin Pract. 2017 Oct;7(5):413-414. doi: 10.1212/CPJ.0000000000000343. No abstract available.

31.

Barriers and Facilitators for Guidelines with Depression and Anxiety in Parkinson's Disease or Dementia.

Goodarzi Z, Hanson HM, Jette N, Patten S, Pringsheim T, Holroyd-Leduc J.

Can J Aging. 2018 Jun;37(2):185-199. doi: 10.1017/S0714980818000053. Epub 2018 Apr 5.

PMID:
29618389
32.

Validating screening tools for depression in Parkinson's disease.

Kadhim S, Pringsheim T, Le A, Fiest KM, Patten SB, Prisnie JC, Gill S, Bulloch AGM, Hu B, Jette N.

Mov Disord. 2018 Jul;33(7):1184-1186. doi: 10.1002/mds.27371. Epub 2018 Mar 24. No abstract available.

PMID:
29573354
33.

Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada.

Chen W, Cepoiu-Martin M, Stang A, Duncan D, Symonds C, Cooke L, Pringsheim T.

Clin Drug Investig. 2018 May;38(5):449-455. doi: 10.1007/s40261-018-0626-4.

PMID:
29453686
34.

Clinical Utility of Screening for Anxiety and Depression in Children with Tourette Syndrome.

Marwitz L, Pringsheim T.

J Can Acad Child Adolesc Psychiatry. 2018 Jan;27(1):15-21. Epub 2018 Jan 1.

35.

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27.

36.

Tourette syndrome and other chronic tic disorders: an update on clinical management.

Martino D, Pringsheim TM.

Expert Rev Neurother. 2018 Feb;18(2):125-137. doi: 10.1080/14737175.2018.1413938. Epub 2017 Dec 8. Review.

PMID:
29219631
37.

Detecting anxiety in individuals with Parkinson disease: A systematic review.

Mele B, Holroyd-Leduc J, Smith EE, Pringsheim T, Ismail Z, Goodarzi Z.

Neurology. 2018 Jan 2;90(1):e39-e47. doi: 10.1212/WNL.0000000000004771. Epub 2017 Dec 6.

PMID:
29212828
38.

Neurology and mental health.

Pringsheim T.

Neurol Clin Pract. 2017 Apr;7(2):96-97. doi: 10.1212/CPJ.0000000000000345. No abstract available.

39.

Functional movement disorders: Five new things.

Pringsheim T, Edwards M.

Neurol Clin Pract. 2017 Apr;7(2):141-147. doi: 10.1212/CPJ.0000000000000350.

40.

Feasibility and Relevance of Antipsychotic Safety Monitoring in Children With Tourette Syndrome: A Prospective Longitudinal Study.

Pringsheim T, Ho J, Sarna JR, Hammer T, Patten S.

J Clin Psychopharmacol. 2017 Oct;37(5):498-504. doi: 10.1097/JCP.0000000000000760.

PMID:
28816926
41.

Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics.

Martino D, Ganos C, Pringsheim TM.

Int Rev Neurobiol. 2017;134:1461-1490. doi: 10.1016/bs.irn.2017.05.006. Epub 2017 Jun 9. Review.

PMID:
28805580
42.

Canadian Schizophrenia Guidelines: Introduction and Guideline Development Process.

Pringsheim T, Addington D.

Can J Psychiatry. 2017 Sep;62(9):586-593. doi: 10.1177/0706743717719897. Epub 2017 Aug 9. Review.

43.

Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.

Abidi S, Mian I, Garcia-Ortega I, Lecomte T, Raedler T, Jackson K, Jackson K, Pringsheim T, Addington D.

Can J Psychiatry. 2017 Sep;62(9):635-647. doi: 10.1177/0706743717720197. Epub 2017 Aug 2. Review.

44.

Physical Health and Drug Safety in Individuals with Schizophrenia.

Pringsheim T, Kelly M, Urness D, Teehan M, Ismail Z, Gardner D.

Can J Psychiatry. 2017 Sep;62(9):673-683. doi: 10.1177/0706743717719898. Epub 2017 Jul 18. Review.

45.

Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies.

Hirsch L, Yang J, Bresee L, Jette N, Patten S, Pringsheim T.

Drug Saf. 2017 Sep;40(9):771-781. doi: 10.1007/s40264-017-0543-0. Review.

PMID:
28585153
46.

Smoking, alcohol and drug use in youth and adults with attention-deficit hyperactivity disorder.

Osland S, Hirsch L, Pringsheim T.

BJPsych Open. 2017 May 19;3(3):141-146. doi: 10.1192/bjpo.bp.116.004317. eCollection 2017 May.

47.

Tics in the Pediatric Population: Pragmatic Management.

Ganos C, Martino D, Pringsheim T.

Mov Disord Clin Pract. 2017 Mar-Apr;4(2):160-172. doi: 10.1002/mdc3.12428. Epub 2016 Nov 11. Review.

48.

Reply to "Screening tools for tic disorders - Focus on development or implementation?"

Martino D, Pringsheim TM.

Mov Disord. 2017 Jun;32(6):947. doi: 10.1002/mds.26986. Epub 2017 Apr 24. No abstract available.

PMID:
28436554
49.

Determinants of neurological disease: Synthesis of systematic reviews.

Krewski D, Barakat-Haddad C, Donnan J, Martino R, Pringsheim T, Tremlett H, van Lieshout P, Walsh SJ, Birkett NJ, Gomes J, Little J, Bowen S, Candundo H, Chao TK, Collins K, Crispo JAG, Duggan T, El Sherif R, Farhat N, Fortin Y, Gaskin J, Gupta P, Hersi M, Hu J, Irvine B, Jahanfar S, MacDonald D, McKay K, Morrissey A, Quach P, Rashid R, Shin S, Sikora L, Tkachuk S, Taher MK, Wang MD, Darshan S, Cashman NR.

Neurotoxicology. 2017 Jul;61:266-289. doi: 10.1016/j.neuro.2017.04.002. Epub 2017 Apr 12. Review.

PMID:
28410962
50.

Assessment and Treatment of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents: Creation and Dissemination of a National Curriculum.

Pringsheim T, Andrade B, Doja A, Gorman DA.

Can J Psychiatry. 2017 Jun;62(6):431-432. doi: 10.1177/0706743716679818. Epub 2017 Apr 7. No abstract available.

Supplemental Content

Loading ...
Support Center